Literature DB >> 11346646

Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048.

T H van Dijk1, F H van der Sluijs, C H Wiegman, J F Baller, L A Gustafson, H J Burger, A W Herling, F Kuipers, A J Meijer, D J Reijngoud.   

Abstract

Effects of acute inhibition of glucose-6-phosphatase activity by the chlorogenic acid derivative S4048 on hepatic carbohydrate fluxes were examined in isolated rat hepatocytes and in vivo in rats. Fluxes were calculated using tracer dilution techniques and mass isotopomer distribution analysis in plasma glucose and urinary paracetamol-glucuronide after infusion of [U-(13)C]glucose, [2-(13)C]glycerol, [1-(2)H]galactose, and paracetamol. In hepatocytes, glucose-6-phosphate (Glc-6-P) content, net glycogen synthesis, and lactate production from glucose and dihydroxyacetone increased strongly in the presence of S4048 (10 microm). In livers of S4048-treated rats (0.5 mg kg(-1)min(-)); 8 h) Glc-6-P content increased strongly (+440%), and massive glycogen accumulation (+1260%) was observed in periportal areas. Total glucose production was diminished by 50%. The gluconeogenic flux to Glc-6-P was unaffected (i.e. 33.3 +/- 2.0 versus 33.2 +/- 2.9 micromol kg(-1)min(-1)in control and S4048-treated rats, respectively). Newly synthesized Glc-6-P was redistributed from glucose production (62 +/- 1 versus 38 +/- 1%; p < 0.001) to glycogen synthesis (35 +/- 5% versus 65 +/- 5%; p < 0.005) by S4048. This was associated with a strong inhibition (-82%) of the flux through glucokinase and an increase (+83%) of the flux through glycogen synthase, while the flux through glycogen phosphorylase remained unaffected. In livers from S4048-treated rats, mRNA levels of genes encoding Glc-6-P hydrolase (approximately 9-fold), Glc-6-P translocase (approximately 4-fold), glycogen synthase (approximately 7-fold) and L-type pyruvate kinase (approximately 4-fold) were increased, whereas glucokinase expression was almost abolished. In accordance with unaltered gluconeogenic flux, expression of the gene encoding phosphoenolpyruvate carboxykinase was unaffected in the S4048-treated rats. Thus, acute inhibition of glucose-6-phosphatase activity by S4048 elicited 1) a repartitioning of newly synthesized Glc-6-P from glucose production into glycogen synthesis without affecting the gluconeogenic flux to Glc-6-P and 2) a cellular response aimed at maintaining cellular Glc-6-P homeostasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346646     DOI: 10.1074/jbc.M101223200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Hepatic glucose sensing and integrative pathways in the liver.

Authors:  Maaike H Oosterveer; Kristina Schoonjans
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

2.  Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism.

Authors:  Ayman M Mahmoud; Sanaa M Abd El-Twab; Eman S Abdel-Reheim
Journal:  Eur J Nutr       Date:  2016-04-08       Impact factor: 5.614

3.  Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice.

Authors:  R H J Bandsma; A Grefhorst; T H van Dijk; F H van der Sluijs; A Hammer; D-J Reijngoud; F Kuipers
Journal:  Diabetologia       Date:  2004-12-01       Impact factor: 10.122

Review 4.  The glucose-6-phosphatase system.

Authors:  Emile van Schaftingen; Isabelle Gerin
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

Review 5.  The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature.

Authors:  Narges Tajik; Mahboubeh Tajik; Isabelle Mack; Paul Enck
Journal:  Eur J Nutr       Date:  2017-04-08       Impact factor: 5.614

6.  Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.

Authors:  Sara Abbadi; Julio J Rodarte; Ameer Abutaleb; Emily Lavell; Chris L Smith; William Ruff; Jennifer Schiller; Alessandro Olivi; Andre Levchenko; Hugo Guerrero-Cazares; Alfredo Quinones-Hinojosa
Journal:  Mol Cancer Res       Date:  2014-07-07       Impact factor: 5.852

7.  Studies of ApoD-/- and ApoD-/-ApoE-/- mice uncover the APOD significance for retinal metabolism, function, and status of chorioretinal blood vessels.

Authors:  Nicole El-Darzi; Natalia Mast; Alexey M Petrov; Tung Dao; Artem A Astafev; Aicha Saadane; Erin Prendergast; Emmy Schwarz; Ilya Bederman; Irina A Pikuleva
Journal:  Cell Mol Life Sci       Date:  2020-05-21       Impact factor: 9.261

8.  Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes.

Authors:  Michaela Kacerovsky; John Jones; Albrecht I Schmid; Cristina Barosa; Angelika Lettner; Gertrud Kacerovsky-Bielesz; Julia Szendroedi; Marek Chmelik; Peter Nowotny; Visvanathan Chandramouli; Michael Wolzt; Michael Roden
Journal:  Diabetes       Date:  2011-05-11       Impact factor: 9.461

9.  Org 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic index.

Authors:  Marie-José C van Lierop; Wynand Alkema; Anke J Laskewitz; Rein Dijkema; Hans M van der Maaden; Martin J Smit; Ralf Plate; Paolo G M Conti; Christan G J M Jans; C Marco Timmers; Constant A A van Boeckel; Scott J Lusher; Ross McGuire; Rene C van Schaik; Jacob de Vlieg; Ruben L Smeets; Claudia L Hofstra; Annemieke M H Boots; Marcel van Duin; Benno A Ingelse; Willem G E J Schoonen; Aldo Grefhorst; Theo H van Dijk; Folkert Kuipers; Wim H A Dokter
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

10.  Noninvasive measurement of murine hepatic acetyl-CoA ¹³C-enrichment following overnight feeding with ¹³C-enriched fructose and glucose.

Authors:  Filipa Carvalho; Joao Duarte; Ana Rita Simoes; Pedro F Cruz; John G Jones
Journal:  Biomed Res Int       Date:  2013-06-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.